Showing results (1021-1030 of 6,501) with videos related to

Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|January 1, 1996
Inhibition of rat C6 glioblastoma tumor growth by expression of insulin-like growth factor I receptor antisense mRNAM Resnicoff, W Li, S Basak, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1996
T cell receptor Vbeta repertoire of tumour-infiltrating lymphocytes in oral squamous-cell carcinomaS H Lim, D W Thomas, S Coleman, et al.
Cancer Immunology, Immunotherapy : CII|March 1, 1996
Therapeutic effectiveness of the immunity elicited by P815 tumor cells engineered to express the B7-2 costimulatory moleculeR N La Motte, M A Rubin, E Barr, et al.
Cancer Immunology, Immunotherapy : CII|March 1, 1996
Humoral and cellular responses raised against the human HER2 oncoprotein are cross-reactive with the homologous product of the new proto-oncogene, but do not protect rats against B104 tumors expressing mutated neuP Taylor, M Gerder, Z Moros, et al.
Cancer Immunology, Immunotherapy : CII|March 1, 1996
Characterisation of the complement-regulatory proteins decay-accelerating factor (DAF, CD55) and membrane cofactor protein (MCP, CD46) on a human colonic adenocarcinoma cell lineL Bjørge, T S Jensen, R Matre
Cancer Immunology, Immunotherapy : CII|March 1, 1996
Autoantibodies against p53 are not increased in human ascites and pleural effusionsR Munker, O Stötzer, M Darsow, et al.
Cancer Immunology, Immunotherapy : CII|December 1, 1995
Suppression of in vivo tumor growth by the transfection of the interleukin-5 gene into colon tumor cellsY Masuda, S Mita, K Sakamoto, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 1996
In vivo evaluation of epidermal growth factor (EGF) receptor density on human tumor xenografts using radiolabeled EGF and anti-(EGF receptor) mAb 425R Senekowitsch-Schmidtke, K Steiner, J Haunschild, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1993
The role of monoclonal antibody A7 as a drug modifier in cancer therapyK Kitamura, T Miyagaki, N Yamaoka, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1993
Restricted T cell receptor V-beta and J-beta usage in T cells from interleukin-2-cultured lymphocytes of ovarian and renal carcinomasE Halapi, Y Yamamoto, C Juhlin, et al.
Pageof 651